REVIEW ARTICLE |
|
Year : 2020 | Volume
: 10
| Issue : 2 | Page : 74-78 |
|
Povidone-iodine: “The first line of defense” with potential anti-severe acute respiratory syndrome coronavirus-2 efficacy
Nishant Negi1, Vinay Kumar Bhardwaj2, Deepak Sharma3, Rajiv Sharma1, Toufiq Asad1, Abdul Shamal1
1 Department of Orthodontics and Dentofacial Orthopaedics, H.P. Government Dental College and Hospital, Shimla, Himachal Pradesh, India 2 Department of Public Health Dentistry, H.P. Government Dental College and Hospital, Shimla, Himachal Pradesh, India 3 Department of Periodontology, H.P. Government Dental College and Hospital, Shimla, Himachal Pradesh, India
Correspondence Address:
Dr. Deepak Sharma Department of Periodontology, H.P. Government. Dental College and Hospital, Shimla - 171 001, Himachal Pradesh India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ijohs.ijohs_24_20
|
|
An outbreak of new coronavirus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV2) (coronavirus disease-19), has assumed the proportion of global pandemic having affected more than 200 countries and territories. In the absence of any specific treatment, efficient disinfectant and antiseptic products are useful to help prevent the spread of infection. Povidone-iodine formulations are well known for their broad-spectrum antimicrobial action and a remarkable safety profile. They have shown in vitro virucidal activity against different coronaviruses. Till the time there is a concrete clinical evidence of efficacy of antiseptic agents against the current coronavirus, povidone-iodine formulations can be used widely as first choice antiseptics as well as for preventive and prophylactic management of SARS-CoV2 infection. This review highlights the importance of Povidone-Iodine formulations in health-care settings as broad-spectrum antiseptic, especially because of their potential virucidal activity against SARS-CoV2.
|
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|